148 related articles for article (PubMed ID: 25227788)
21. Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.
Mo Q; Zhang Y; Jin X; Gao Y; Wu Y; Hao X; Gao Q; Chen P
Tumour Biol; 2016 Nov; 37(11):14745-14755. PubMed ID: 27629142
[TBL] [Abstract][Full Text] [Related]
22. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition.
Huang Z; Zhou X; He Y; Ke X; Wen Y; Zou F; Chen X
Sci Rep; 2016 Dec; 6():38072. PubMed ID: 27909289
[TBL] [Abstract][Full Text] [Related]
25. Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.
Gao RJ; Liang YX; Li DD; Zhang HY; Zhen YS
Biomed Environ Sci; 2007 Jun; 20(3):189-97. PubMed ID: 17672208
[TBL] [Abstract][Full Text] [Related]
26. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
[TBL] [Abstract][Full Text] [Related]
27. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
Liu HZ; Li DD; Zhen YS; Shao RG
Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
[TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
[TBL] [Abstract][Full Text] [Related]
29. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
[TBL] [Abstract][Full Text] [Related]
30. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.
Zhen HY; He QH; Zhen YZ; Wang SL; Liu YN; Wu WH; Zhang XY; Lu AL; Shen L
Invest New Drugs; 2011 Dec; 29(6):1188-97. PubMed ID: 20596749
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
33. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
[TBL] [Abstract][Full Text] [Related]
34. HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis.
Zhang MH; Lee JS; Kim HJ; Jin DI; Kim JI; Lee KJ; Seo JS
Mol Cell Biochem; 2006 Jan; 281(1-2):111-21. PubMed ID: 16328963
[TBL] [Abstract][Full Text] [Related]
35. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of geldanamycin and antitumor drugs.
Liao ZY; Zhang SH; Zhen YS
Yao Xue Xue Bao; 2001 Aug; 36(8):569-75. PubMed ID: 12579931
[TBL] [Abstract][Full Text] [Related]
37. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS
Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252
[TBL] [Abstract][Full Text] [Related]
38. Effects of lidamycin on genomic DNA in human hepatoma BEL-7402 cells.
He QY; Jiang B; Li DD
Acta Pharmacol Sin; 2002 Mar; 23(3):253-6. PubMed ID: 11918851
[TBL] [Abstract][Full Text] [Related]
39. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
Zhang SH; Chen J; Jiang M; Zhen YS
Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
[TBL] [Abstract][Full Text] [Related]
40. Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.
Liang YX; Zhang W; Li DD; Liu HT; Gao P; Sun YN; Shao RG
World J Gastroenterol; 2004 Sep; 10(18):2632-6. PubMed ID: 15309709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]